Content overview: “Cancer Vaccines Are Finally Here—But Can We Get Them to Patients Faster Than BRCA Testing?”. Cancer vaccines are no longer a distant dream—they are here, but getting them to patients quickly will require overcoming major hurdles now, warn experts Karen E. Knudsen, CEO of the American Cancer Society, and Othman Laraki, CEO of Color Health. Drawing a stark comparison to the slow adoption of B Drawing a stark comparison to the slow adoption of BRCA genetic testing, they argue that without immediate action, these breakthroughs could take decades to reach those who need them.
The challenges include complex manufacturing, high costs, and a healthcare system not designed for personalized therapies. Knudsen and Laraki emphasize the need for new infrastructure, streamlined regulation, and equitable access to avoid repeating past delays. The stakes are enormous: cancer vaccines could transform treatment for millions, but only if we build the pathways to deliver them. This listing links straight to the original page, where the content is available in full.